--- title: "NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024" ocid: "ocds-h6vhtk-040e74" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-040e74" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-040e74.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-040e74.json" source: "Find A Tender Service" current_stage: "Award" buyer: "NHS ENGLAND" published: "2024-02-26" --- # NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Buyer: NHS ENGLAND Current stage: Award OCID: ocds-h6vhtk-040e74 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-040e74) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-040e74.json) ## Summary The public procurement contracting process is currently in the Tender stage by the buying organisation, focusing on the provision of construction services in the education industry category. The tender is located in London, UK, with a submission deadline of 30th September 2021. This presents an opportunity for construction companies specialising in education infrastructure projects to compete and potentially secure a contract. The contracting authority seeking construction services for an education project in London sets a clear deadline for interested businesses to submit their bids. The competitive nature of the Tender stage allows construction companies with relevant experience in the education sector to showcase their capabilities and potentially expand their business portfolio through successful contract award. ## Notice Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months ### Lot Information CM/PHR/22/5678/01 CM/PHR/22/5678/01 - NHS Framework for North of England Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 NHS Framework for North of England Branded Medicines - Lot 2. (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/04 CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/006097-2024 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 26 Feb 2024 | | Submission deadline | 24 Nov 2023 | | Future notice date | Not specified | | Award date | 26 Jan 2024 | | Contract period | 1 Mar 2024 - 31 Aug 2025 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1,833,333,000 | | Lots value | £1,833,334,000 | | Awards value | Not specified | | Contracts value | £1 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Locality | LEEDS | | Post town | Leeds | | Postcode | LS2 7UE | | Country | England | | ITL 1 | TLE Yorkshire and The Humber | | ITL 2 | TLE4 West Yorkshire | | ITL 3 | TLE42 Leeds | | Local authority | Leeds | | Electoral ward | Little London & Woodhouse | | Westminster constituency | Leeds Central and Headingley | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 38 | | Supplier names | ABBVIE; ACCORD-UK; ALMIRALL; AMGEN; ASTRAZENECA; AVENTIS PHARMA LTD T/A SANOFI; BAYER; BIOGEN; CELLTRION HEALTHCARE UNITED KINGDOM; CHUGAI PHARMA; CST PHARMA; DR.REDDY'S LABORATORIES (UK; ELI LILLY; GALAPAGOS BIOTECH; GEDEON RICHTER; GLAXOSMITHKLINE; IPSEN; JANSSEN-CILAG; MERCK SERONO; MERCK SHARPE AND DOHME (UK; MERZ; MYLAN; NAPP PHARMACEUTICALS; NEON HEALTHCARE; NOVARTIS PHARMACEUTICALS; NOVO NORDISK; ORGANON PHARMACEUTICALS; ORIFARM; PFIZER; PHARMACOSMOS; ROCHE PRODUCTS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; SUN PHARMA; TEVA; THORNTON AND ROSS; VIFOR PHARMA; ZENTIVA PHARMA | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 26 Feb 2024 at 12:50 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/006097-2024 - 24 Oct 2023 at 10:06 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/031307-2023 - 24 Oct 2023 at 09:12 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/031292-2023 ## Notice URLs - https://health-family.force.com/s/Welcome - https://www.england.nhs.uk/ - https://www.judiciary.uk/courts-and-tribunals/high-court/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-040e74. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-040e74.json.